Group One Trading’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$459K Sell
50,286
-7,098
-12% -$64.7K ﹤0.01% 692
2025
Q1
$456K Buy
+57,384
New +$456K ﹤0.01% 598
2024
Q4
Hold
0
3218
2024
Q3
Sell
-399,305
Closed -$4.34M 2874
2024
Q2
$4.34M Buy
399,305
+362,916
+997% +$3.94M 0.02% 132
2024
Q1
$682K Buy
36,389
+34,408
+1,737% +$645K ﹤0.01% 407
2023
Q4
$42.9K Sell
1,981
-35,958
-95% -$779K ﹤0.01% 1099
2023
Q3
$781K Buy
37,939
+25,527
+206% +$525K ﹤0.01% 423
2023
Q2
$584K Sell
12,412
-2,029
-14% -$95.4K ﹤0.01% 443
2023
Q1
$606K Sell
14,441
-5,698
-28% -$239K ﹤0.01% 414
2022
Q4
$768K Sell
20,139
-1,333
-6% -$50.8K ﹤0.01% 432
2022
Q3
$841K Buy
21,472
+6,514
+44% +$255K ﹤0.01% 449
2022
Q2
$483K Buy
14,958
+14,484
+3,056% +$468K ﹤0.01% 631
2022
Q1
$16K Sell
474
-1,875
-80% -$63.3K ﹤0.01% 1686
2021
Q4
$100K Sell
2,349
-7,000
-75% -$298K ﹤0.01% 1391
2021
Q3
$414K Sell
9,349
-80,926
-90% -$3.58M ﹤0.01% 896
2021
Q2
$5.13M Buy
90,275
+84,212
+1,389% +$4.78M 0.01% 231
2021
Q1
$454K Buy
+6,063
New +$454K ﹤0.01% 801
2020
Q4
Sell
-10,898
Closed -$666K 2451
2020
Q3
$666K Sell
10,898
-16,185
-60% -$989K ﹤0.01% 470
2020
Q2
$1.13M Sell
27,083
-6,983
-20% -$290K 0.01% 275
2020
Q1
$978K Buy
+34,066
New +$978K 0.01% 244
2019
Q4
Sell
-3,627
Closed -$509K 2038
2019
Q3
$509K Buy
+3,627
New +$509K ﹤0.01% 378
2019
Q2
Hold
0
1933
2019
Q1
Sell
-8,166
Closed -$782K 1883
2018
Q4
$782K Buy
+8,166
New +$782K 0.01% 298
2018
Q3
Hold
0
1978
2018
Q2
Hold
0
1896
2018
Q1
Hold
0
1834
2017
Q4
Sell
-1,823
Closed -$114K 1841
2017
Q3
$114K Sell
1,823
-5,589
-75% -$350K ﹤0.01% 756
2017
Q2
$590K Sell
7,412
-2,018
-21% -$161K 0.01% 382
2017
Q1
$670K Buy
9,430
+8,090
+604% +$575K 0.01% 310
2016
Q4
$68K Buy
+1,340
New +$68K ﹤0.01% 755
2016
Q3
Sell
-5,700
Closed -$172K 1670
2016
Q2
$172K Buy
5,700
+5,100
+850% +$154K ﹤0.01% 499
2016
Q1
$19K Buy
+600
New +$19K ﹤0.01% 908
2015
Q4
Sell
-5,000
Closed -$212K 1762
2015
Q3
$212K Buy
5,000
+2,745
+122% +$116K ﹤0.01% 574
2015
Q2
$165K Buy
+2,255
New +$165K ﹤0.01% 641